146 filings
Page 4 of 8
8-K
rx0yzs3yjuxdci6e
12 May 20
Departure of Directors or Certain Officers
12:00am
8-K
mbeo7mm 4laj4sgz2
10 Jan 20
Update on CURE's Investment in Coeptis Pharmaceuticals, Inc
5:03pm
8-K/A
r7efaixx62vs 7z
31 Dec 19
Completion of Acquisition or Disposition of Assets
12:15pm
8-K
6ez6s4ojubhewziwd38
21 Nov 19
CURE Pharmaceutical Names Canopy Rivers’ Chairman, John K. Bell, To Board of Directors
4:03pm
8-K
ai0 wr9vfeiohin
14 Nov 19
Entry into a Material Definitive Agreement
11:52am
8-K
yx77j0mc2z
4 Oct 19
Material Modifications to Rights of Security Holders
2:07pm
8-K
lms7ge 8ddftarc65
9 Aug 19
Submission of Matters to a Vote of Security Holders
12:00am
UPLOAD
vru1b akl05a
3 Jul 19
Letter from SEC
12:00am
CORRESP
zhcevubac4lkrb
2 Jul 19
Correspondence with SEC
12:00am
UPLOAD
5rfy2hc aaxy
27 Jun 19
Letter from SEC
12:00am
PRER14A
0i6eoi5h flev
26 Jun 19
Preliminary revised proxy
3:54pm
CORRESP
1n6u8qfsx7iv4xo
26 Jun 19
Correspondence with SEC
12:00am
UPLOAD
phl3fdet40
24 Jun 19
Letter from SEC
12:00am
PRE 14A
r3g760
14 Jun 19
Preliminary proxy
5:27pm